HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christine Bergeron Selected Research

Atypical Squamous Cells of the Cervix

1/2019Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
1/2014HPV testing and vaccination in Europe.
10/2012p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis.
6/2011p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.
7/2010The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results.
2/2007Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
1/2006Human papillomavirus testing with a liquid-based system: feasibility and comparison with reference diagnoses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christine Bergeron Research Topics

Disease

7Atypical Squamous Cells of the Cervix
01/2019 - 01/2006
6Papillomavirus Infections
06/2015 - 07/2010
6Uterine Cervical Dysplasia
11/2012 - 11/2008
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 01/2008
5Squamous Intraepithelial Lesions
01/2020 - 07/2010
4Leiomyoma (Uterine Fibroids)
05/2019 - 11/2012
4Neoplasms (Cancer)
04/2012 - 10/2006
1Anus Neoplasms (Anal Cancer)
01/2018
1Margins of Excision
12/2017
1Penile Neoplasms (Penile Cancer)
01/2016
1Ependymoma
12/2014
1Polyps
11/2012
1Hyperplasia
11/2012
1Myoma
11/2012
1Hemorrhage
11/2012
1Endometriosis
05/2008
1Condylomata Acuminata (Genital Wart)
01/2008
1Carcinogenesis
10/2006
1Endometrioid Carcinoma
08/2006
1Adenomyosis
08/2006

Drug/Important Bio-Agent (IBA)

7Cyclin-Dependent Kinase Inhibitor p16IBA
01/2016 - 10/2006
7Biomarkers (Surrogate Marker)IBA
06/2015 - 10/2006
6DNA (Deoxyribonucleic Acid)IBA
01/2019 - 11/2008
3ulipristal acetateFDA Link
11/2018 - 11/2012
3Progesterone Receptors (Progesterone Receptor)IBA
06/2013 - 05/2008
2Papillomavirus Vaccines (HPV Vaccines)IBA
01/2018 - 01/2008
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2012 - 08/2006
2Coloring Agents (Dyes)IBA
06/2011 - 07/2010
1Combined VaccinesIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2016
1VaccinesIBA
11/2012
1RNA (Ribonucleic Acid)IBA
06/2012
1Complement System Proteins (Complement)IBA
06/2011
1Danazol (Azol)FDA LinkGeneric
08/2006
1Hormones (Hormone)IBA
08/2006
1Fixatives (Pickling Agents)IBA
01/2006

Therapy/Procedure

3Hysterectomy
05/2019 - 08/2006
3Aftercare (After-Treatment)
12/2017 - 11/2012
1Cytoreduction Surgical Procedures
12/2014